Steroids: why does the NFL get a free pass?

Leave a comment

Headline to a column written in the Philadelphia Daily News: “NFL seems to have better handle on steroid problem than MLB.”

The keyword is “seems.” According to the article, steroid use was de rigueur in the NFL back in the 80s in a way that it has never been alleged to be in baseball. Ex-lineman Brian Baldinger:

“I remember the first day of training camp, going into Player X’s
dorm room when the vets showed up,” says Baldinger, who played 11 NFL
seasons for the Cowboys, Eagles and Indianapolis Colts. “A brown bag
was dumped out on the bed full of syringes and you name it. And you
just kind of grabbed what you needed.

“It wasn’t like it is now, with baseball players saying, ‘Let’s get
the playing field even.’ Back then, it was understood that X-amount of
players, mostly linemen, that’s what they did [use steroids]. It wasn’t
looked at as a competitive advantage.”

In light of that culture the NFL, to its credit, instituted steroids
testing in the 1980s. And it has had some success. According to the
article, anonymous post-retirement surveys by a medical journal
indicated a 20.3% rate of steroid use among respondents in the 1980s
and a 12.7% rate currently. While it’s not unreasonable to assume that
the actual usage rate is higher simply because human nature does not
easily allow people to admit bad stuff, let’s just say that 12.7% is
accurate.

So rates are lower, but is that any basis to claim — as the people
quoted in this article claim — that the NFL’s testing regime
represents success? 12.7% of current NFL rosters equals roughly 215
players. In the past four years, however, a total of 43
players have been suspended for violating the NFL’s PED policy, or
about 10 a year. I’ll spare you the math, but trust me when I tell you
that 10 a year is somewhat less than 12.7%.

Yet despite this — and despite the fact that the no one has ever
provided any data suggesting that as many as 12.7% of baseball players
are using PEDs at any given time in the testing era — football is held
up as having its PED house in better order than baseball. And that’s
before you apply the same “look how big those dudes are” logic to
football that is so often applied to baseball.

I won’t claim that baseball’s testing regime is perfect — it’s
actually less comprehensive on paper than the NFL’s — but I find it
incredible that the NFL is given a virtual free pass when it comes to
steroids while baseball’s drug problems are continually dragged out for
public ridicule and abuse.

Brewers to give Mike Moustakas a look at second base

Thearon W. Henderson/Getty Images
8 Comments

The Brewers reportedly signed third baseman Mike Moustakas to a one-year, $10 million contract on Sunday. While the deal is not yet official, MLB.com’s Adam McCalvy reports that the Brewers plan to give Moustakas a look at second base during spring training. If all goes well, he will be the primary second baseman and Travis Shaw will stay at third base.

The initial thought was that Moustakas would simply take over at third base for the more versatile Shaw. Moustakas has spent 8,035 of his career defensive innings at third base, 35 innings at first base, and none at second. In fact, he has never played second base as a pro player. Shaw, meanwhile, has spent 268 of his 4,073 1/3 defensive innings in the majors at second base and played there as recently as October.

This is certainly an interesting wrinkle to signing Moustakas, who is a decent third baseman. He was victimized by another slow free agent market, not signing until March last year on a $6.5 million deal with a $15 million mutual option for this season. That option was declined, obviously, and he ended up signing for $5 million cheaper here in February as the Brewers waited him out. Notably, Moustakas did not have qualifying offer compensation attached to him this time around.

Last season, between the Royals and Brewers, the 30-year-old Moustakas hit .251/.315/.459 with 28 home runs and 95 RBI in 635 plate appearances.